What factors reliably predict electronic cigarette nicotine delivery?
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Blank (2020)
Smoking-related weight and appetite concerns and use of electronic cigarettes among daily cigarette smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Bloom (2019)
abuse liability of electronic cigarettes in men who are experienced electronic cigarette users.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Breland (2020)
The Unhealthy association Between Smoking, Vaping, and Other Drug Use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Bruijnzeel (2022)
Cannabis use and electronic cigarette use: The role of dual use on use frequency and related problems.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Buckner (2021)
The Influence of Risk and Protective Factors on adolescent alcohol, Cannabis, and Electronic Cigarette Use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Burrow-Sánchez (2022)
Part one: abuse liability of Vuse Solo (G2) electronic nicotine delivery system relative to combustible cigarettes and nicotine gum.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Campbell (2022)
A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes
Individual Clinical
Pharmacokinetics & Abuse Liability
ALL
Chapman (2022)
Electromembrane extraction of nicotine in inhaled aerosols from tobacco cigarettes, electronic cigarettes, and heated tobacco products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Chen (2022)
Electronic Cigarettes and alternative Methods of Vaping.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Choi (2021)